STAT

STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug classWorldPing

The FDA approved a treatment for advanced multiple myeloma made by Bristol Myers Squibb, marking the debut of a new class of drugs for the blood cancer.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

Related news